Top Tweets for #ILCC26

11 days ago

Building on the progress made in lung cancer management, @christine_lovly overviews the key challenges and barriers that still need to be addressed to advance care for this patient population @gotoPER #gotoPER #ILCC26 #lcsm #oncology https://t.co/7pp7i31uHm

OncLive.com

@OncLive

11 days ago

Experts go step by step in laying out their thought processes and treatment selections for difficult-to-treat lung cancer cases. @NarjustFlorezMD @LeXiuning @UCSDMedSchool @DanaFarber @harvardmed @gotoPER #ILCC26 #lcsm #oncology https://t.co/e9HFiKxHbs

831

OncLive.com

@OncLive

11 days ago

733

OncLive.com

@OncLive

13 days ago

Despite research efforts, docetaxel has not been displaced as a SOC in immunotherapy-refractory NSCLC. @peters_solange discusses the efforts to improve later-line treatment options for this patient population @gotoPER #gotoPER #ILCC26 #lcsm #oncology https://t.co/bLjp6OcFGW

$OncLive's tweet photo. Despite research efforts, docetaxel has not been displaced as a SOC in immunotherapy-refractory NSCLC. @peters_solange discusses the efforts to improve later-line treatment options for this patient population @gotoPER #gotoPER #ILCC26 #lcsm #oncology https://t.co/bLjp6OcFGW https://t.co/R5yZzX9oX1$

OncLive.com

@OncLive

16 days ago

The sun is setting on day 1 of #ILCC26, but we’ll see you tomorrow for another day of expert-led discussions in #lcsm @HwakeleeMD @PatelOncology @DrRoyHerbst

OncLive's tweet photo. The sun is setting on day 1 of #ILCC26, but we’ll see you tomorrow for another day of expert-led discussions in #lcsm @HwakeleeMD @PatelOncology @DrRoyHerbst https://t.co/10GgEgigkL

OncLive.com

@OncLive

16 days ago

Last, but certainly not least. Thank you @peters_solange for sitting down with us to talk about how the field is going to tackle the heterogeneity of IO-refractory NSCLC at #ILCC26 #lcsm @unil

$OncLive's tweet photo. Last, but certainly not least. Thank you @peters_solange for sitting down with us to talk about how the field is going to tackle the heterogeneity of IO-refractory NSCLC at #ILCC26 #lcsm @unil https://t.co/hMjCc4eio2$

OncLive.com

@OncLive

16 days ago

#ILCC26 is off to a great start! Great weather, even better presentations on what’s moving the field of #lcsm forward. See you there! 👋🏼 @HwakeleeMD @DrRoyHerbst @PatelOncology

OncLive's tweet photo. #ILCC26 is off to a great start! Great weather, even better presentations on what’s moving the field of #lcsm forward. See you there! 👋🏼 @HwakeleeMD @DrRoyHerbst @PatelOncology https://t.co/eUGcPV69W6

OncLive.com

@OncLive

16 days ago

Day 1 of #ILCC26 is in full swing! Stop by the OncLive® EGFR Channel booth today and tomorrow to discover the easiest way to stay up to date on the latest advances shaping EGFRm NSCLC. Swing by and say hello! 👋

Sandip Patel MD FASCO @PatelOncology

5 months ago

Great to be back at ILCC with colleagues-Join us this July to discuss hot topics like moving targeted therapy to the earliest stages of NSCLC, AI-assisted approaches in lung cancer, and more! 👉 Register today and join the conversation: https://t.co/cYJSQeckhj @gotoper_ #ILCC26

Top Tweets for #ILCC26

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users